Inicio › Cáncer de pulmón › Pensilvania

Ensayos clínicos de Cáncer de pulmón en Pensilvania

57 estudios sobre Cáncer de pulmón buscan participantes en Pensilvania.

Ciudades en Pensilvania

Texto oficial del estudio (inglés)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Alliance Cancer Specialists - Media, Media
Guthrie Medical Group, Sayre

ReclutandoFase 3

Edades de 18 a 100 · Todos los sexos · Actualizado el 13 nov 2026 · NCT05920356

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Hospital of the University of Pennsylvania, Philadelphia
West Penn Allegheny Health, Pittsburgh

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
y 14 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lehigh Valley Hospital-Cedar Crest, Allentown
UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
y 52 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Clinical Research Associates of Central Pennsylvania, DuBois

Reclutando

Edades de 50 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07168993

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Bryn Mawr Hospital, Bryn Mawr
Penn State Milton S Hershey Medical Center, Hershey
Riddle Memorial Hospital, Media
y 6 más

ReclutandoFase 3

Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Sidney Kimmel Cancer Center, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07458347

Detection of Genetic Markers of Lung Cancer

Hillman Cancer Center, Pittsburgh

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT00280202

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Univ of Pennsylvania, Abramson Cancer Center, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06312137

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Lehigh Valley Health Network, Allentown

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

St. Luke's University Health Network, Bethlehem
Allegheny Cancer Center, Pittsburgh
Reading Hospital - McGlinn Cancer Institute, West Reading

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
y 7 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
y 12 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Cancer Care Associates of York (site 206), York

ReclutandoFase 1/2

Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT03556228

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
IRMC Cancer Center, Indiana
y 6 más

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07059884

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Alliance Cancer Specialists, PC, Horsham
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06060613

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Fox Chase Cancer Center, Philadelphia

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07185997

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Hospital of the University of Pennsylvania, Philadelphia

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07499674

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06287775

Lung Cancer Detection in Never Smokers Using Urine Volatile Organic Compound (VOCs)

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07871656

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Pittsburgh

ReclutandoFase 2

Edades de 18 a 95 · Todos los sexos · Actualizado el 21 oct 2026 · NCT05061550

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

University of Pennsylvania, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06244771

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Philadelphia

ReclutandoFase 1/2

Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Abramson Cancer Center ( Site 0010), Philadelphia

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT06731907

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

WellSpan Medical Oncology and Hematology, Chambersburg
Geisinger Medical Center, Danville
Geisinger Cancer Center Dickson City, Dickson City
y 10 más

ReclutandoFase 2

18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

UPMC-Heritage Valley Health System Beaver, Beaver
UPMC Hillman Cancer Center at Butler Health System, Butler
WellSpan Medical Oncology and Hematology, Chambersburg
y 31 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

Empathic Communication Skills (ECS) Training

University of Pennsylvania (Data Collection Only), Philadelphia
Fox Chase Cancer Center (Data Collection Only), Philadelphia

ReclutandoSe aceptan voluntarios sanos

Edades de 18 a 100 · Todos los sexos · Actualizado el 7 oct 2026 · NCT05456841

MOv19-BBz CAR T Cells in FRa+ Cancers

University of Pennsylvania, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 oct 2026 · NCT07116057

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT04585750

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Alliance Cancer Specialists, Sellersville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06765109

A Registry for People With Lung Cancer

Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT06424327

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07012031

Pemefolacianine for IMI of Lung Cancer

University of Pennsylvania, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07772895

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Christiana Care Health System-Concord Health Center, Chadds Ford
Chambersburg Hospital, Chambersburg
Geisinger Medical Center, Danville
y 17 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 jul 2026 · NCT07315113

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.